Not recruitingEUCTR 2020-003720-16

A double-blind, placebo-controlled, randomized dose-ranging trial to investigate efficacy and safety of intravenous MIJ821 infusion in addition to comprehensive standard of care on the rapid reduct...

This historical record does not confirm current site availability.

Historical research recordMultiple countriesDepression

The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Germany · Netherlands and 2 more locations
Study phase: Phase 2

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: 195
Sponsor: Novartis Pharma AG
Sponsor type: Pharmaceutical company
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 2
Locations: Germany, Netherlands, Poland, ...
Age range: Not clearly listed
Official registry ID: EUCTR 2020-003720-16
Official title: Show the full official title
A double-blind, placebo-controlled, randomized dose-ranging trial to investigate efficacy and safety of intravenous MIJ821 infusion in addition to comprehensive standard of care on the rapid reduct...

Questions about this study?

The HopeStage team will email you.

Recruitment & locations

Not recruiting

Germany · Netherlands · Poland

1 more locations

Slovakia

Registry details

Historical country statuses

Germany — Completed
Netherlands — Prematurely Ended
Poland — Prematurely Ended
Slovakia — Prematurely Ended

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Novartis Pharma AG, a pharmaceutical company.

Is this study still recruiting?

The historical registry lists this study as not recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me